Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$220.43 - $278.69 $211,612 - $267,542
960 New
960 $267,000
Q1 2022

May 10, 2022

SELL
$187.51 - $283.98 $160,883 - $243,654
-858 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$238.08 - $288.0 $204,272 - $247,104
858 New
858 $246,000
Q3 2021

Nov 12, 2021

SELL
$250.72 - $291.24 $226,400 - $262,989
-903 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$235.0 - $310.7 $1,175 - $1,553
-5 Reduced 0.55%
903 $248,000
Q1 2021

May 13, 2021

BUY
$175.6 - $291.43 $159,444 - $264,618
908 New
908 $246,000
Q4 2020

Mar 04, 2021

SELL
$174.98 - $272.83 $231,498 - $360,954
-1,323 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $3,705 - $4,774
-20 Reduced 1.49%
1,323 $257,000
Q2 2020

Jul 23, 2020

BUY
$153.32 - $191.72 $205,908 - $257,479
1,343 New
1,343 $240,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.09B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Mainstay Capital Management LLC Portfolio

Follow Mainstay Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mainstay Capital Management LLC with notifications on news.